Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/j.1365-4632.2004.02053.x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Authors reply: Alpha-1 antitrypsin deficiency associated with increased risks of skin cancer, leukemia, and hepatic cancer: A nationwide cohort study.
J Intern Med
December 2024
Department of Clinical Biochemistry, Zealand University Hospital, Køge, Denmark.
Regarding: Alpha-1 antitrypsin deficiency associated with increased risks of skin cancer, leukemia, and hepatic cancer: A nationwide cohort study.
J Intern Med
December 2024
Medical Clinic III, Gastroenterology, Metabolic Diseases and Intensive Care, University Hospital RWTH Aachen, Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE LIVER), Aachen, Germany.
A unique case of steroid-resistant, giant cellulitis-like Sweet syndrome mimicking alpha-1-antitrypsin deficiency-associated panniculitis: successful treatment with dapsone.
Clin Exp Dermatol
November 2024
Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Physical and mental health trajectories: A longitudinal SF-36 analysis in Alpha-1 antitrypsin deficiency-associated COPD.
Respir Med
November 2024
AlphaNet, Inc., Coral Gables, Florida, United States; Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Medical University of South Carolina, Charleston, SC, United States.
Background: The Short Form 36-Item Health Survey (SF-36) is a health-related quality of life (HRQoL) measure validated in people with chronic obstructive pulmonary disease (COPD). While physical health is often more impaired than mental health in people with COPD, research on alpha-1 antitrypsin deficiency (AATD)-associated COPD is limited. This longitudinal study examines changes in physical and mental health in individuals with AATD and associated factors.
View Article and Find Full Text PDFAlpha 1 antitrypsin augmentation for alpha 1 antitrypsin deficiency associated lung disease.
Cochrane Database Syst Rev
October 2024
Chest Clinic, East Lancashire Hospitals NHS Trust, Blackburn, UK.
Article Synopsis
- The protocol outlines a Cochrane Review focusing on a specific medical intervention.
- The main objective is to evaluate how effective alpha 1 antitrypsin augmentation therapy is for treating respiratory problems in individuals who have alpha 1 antitrypsin deficiency.
- This review aims to provide evidence-based insights into the benefit of this therapy for affected patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!